The STEAM Success Blueprint podcast

An Interview with A Mentor- Dr. Robert Langer, Sc.D. (MIT Institute Professor) on aspects of the Future of Diabetes Medicine Research

0:00
10:49
Rewind 15 seconds
Fast Forward 15 seconds

An Interview with A Mentor- Dr. Robert Langer, Sc.D. (MIT Institute Professor) on aspects of the Future of Diabetes Medicine Research

======

Diabetes therapy is entering a new phase. For decades, the central challenge was how to deliver insulin more safely, more intelligently, and more responsively.

The research work by Dr. Langer has produced a generation of technologies aimed at making therapy more autonomous: glucose-responsive insulin systems, microneedle patches, implantable rescue devices, lipid nanoparticles, and mRNA-based approaches to protein replacement.

At the same time, a separate revolution emerged from pharmacology. GLP-1 receptor agonists, dual GIP/GLP-1 agonists, and now triple GIP/GLP-1/glucagon agonists have changed expectations for the treatment of type 2 diabetes and obesity.


=====

Music by ANDRII KORNIEV from Pixabay

====

Views of this interview reflect those of my guest and I. They don't constitute medical or professional advice. We disclaim any loss in any way.


More episodes from "The STEAM Success Blueprint"